Using LyP-1 (a homing peptide for p32 receptortargeting) to guide NPs carrying endostatin can effectively deliverthe drug to specific sites to achieve strong antiangiogenic effectsin squamous cell carcinoma. The gene discussed is COL18A1; the disease is squamous cell carcinoma.